• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发认知行为疗法以预防青少年抑郁症复发。

Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.

作者信息

Kennard Beth D, Stewart Sunita M, Hughes Jennifer L, Jarrett Robin B, Emslie Graham J

机构信息

University of Texas Southwestern Medical Center at Dallas.

出版信息

Cogn Behav Pract. 2008 Nov 1;15(4):387-399. doi: 10.1016/j.cbpra.2008.02.006.

DOI:10.1016/j.cbpra.2008.02.006
PMID:20535241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2882305/
Abstract

Relapse rates for children and adolescents with major depressive disorder (MDD) range from 30% to 40% within 1 to 2 years after acute treatment. Although relapse rates are high, there have been relatively few studies on the prevention of relapse in youth. While acute phase pharmacotherapy has been shown to reduce symptoms rapidly in depressed youth, children and adolescents frequently report ongoing residual symptoms and often relapse following acute treatment. Recent adult trials have begun examining augmentation with psychosocial treatment after successful medication treatment to enhance medication response and prevent future relapse. This strategy has not yet been examined in youth with depression. Here we present initial efforts to develop a sequential, combination treatment strategy to promoting rapid remission and to prevent relapse in depressed youth. We describe efforts to adapt CBT to prevent relapse (RP-CBT) in youth who respond to pharmacotherapy. The goals of RP-CBT include: preventing relapse, increasing wellness, and developing skills to promote and sustain a healthy emotional lifestyle. We describe the rationale for, components of, and methods used to develop RP-CBT. The results from a small open series sample demonstrate feasibility and indicate that youth appear to tolerate RP-CBT well. A future test of the treatment in a randomized controlled trial is described.

摘要

患有重度抑郁症(MDD)的儿童和青少年在急性治疗后的1至2年内复发率在30%至40%之间。尽管复发率很高,但针对青少年复发预防的研究相对较少。虽然急性期药物治疗已被证明能迅速减轻抑郁青少年的症状,但儿童和青少年经常报告仍有残留症状,并且在急性治疗后常常复发。最近的成人试验已开始研究在药物治疗成功后采用心理社会治疗进行强化,以增强药物反应并预防未来复发。这种策略尚未在抑郁青少年中进行研究。在此,我们展示了为制定一种序贯联合治疗策略所做的初步努力,以促进抑郁青少年快速缓解并预防复发。我们描述了为使认知行为疗法(CBT)适应于预防对药物治疗有反应的青少年复发(RP-CBT)所做的努力。RP-CBT的目标包括:预防复发、增进健康以及培养促进和维持健康情感生活方式的技能。我们描述了开发RP-CBT的基本原理、组成部分和所用方法。一个小样本开放系列的结果证明了其可行性,并表明青少年似乎能很好地耐受RP-CBT。还描述了未来在随机对照试验中对该治疗方法的测试。

相似文献

1
Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.开发认知行为疗法以预防青少年抑郁症复发。
Cogn Behav Pract. 2008 Nov 1;15(4):387-399. doi: 10.1016/j.cbpra.2008.02.006.
2
Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.氟西汀治疗后预防复发认知行为疗法对青少年重度抑郁症的持续疗效
J Am Acad Child Adolesc Psychiatry. 2015 Dec;54(12):991-8. doi: 10.1016/j.jaac.2015.09.014. Epub 2015 Oct 8.
3
Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial.基于应用程序的失眠认知行为疗法对患有失眠和亚临床抑郁症的青少年预防重度抑郁症的有效性:一项随机临床试验。
PLoS Med. 2025 Jan 21;22(1):e1004510. doi: 10.1371/journal.pmed.1004510. eCollection 2025 Jan.
4
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.认知行为疗法预防重度抑郁症药物治疗有反应的儿科患者复发
J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1395-404. doi: 10.1097/CHI.0b013e31818914a1.
5
Sequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depression.氟西汀序贯治疗与复发预防认知行为疗法改善儿童抑郁症的疗效
Am J Psychiatry. 2014 Oct;171(10):1083-90. doi: 10.1176/appi.ajp.2014.13111460.
6
Feasibility of an Integrated Treatment Approach for Youth with Depression, Suicide Attempts, and Substance Use Problems.针对患有抑郁症、有自杀企图和物质使用问题的青少年的综合治疗方法的可行性。
Evid Based Pract Child Adolesc Ment Health. 2021;6(2):155-172. doi: 10.1080/23794925.2021.1888664. Epub 2021 Mar 3.
7
Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.序贯添加认知行为疗法或抗抑郁药物治疗未缓解抑郁症成人的获益。
Am J Psychiatry. 2019 Apr 1;176(4):275-286. doi: 10.1176/appi.ajp.2018.18091075. Epub 2019 Feb 15.
8
The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.《抗抑郁药治疗与心理治疗序贯治疗重性抑郁障碍:序贯模型的荟萃分析与文献综述》
Am J Psychiatry. 2016 Feb 1;173(2):128-37. doi: 10.1176/appi.ajp.2015.15040476. Epub 2015 Oct 20.
9
Rational-emotive and cognitive-behavior therapy (REBT/CBT) versus pharmacotherapy versus REBT/CBT plus pharmacotherapy in the treatment of major depressive disorder in youth; a randomized clinical trial.理性情绪行为疗法(REBT/CBT)与药物治疗与 REBT/CBT 联合药物治疗在青少年重度抑郁症治疗中的比较;一项随机临床试验。
Psychiatry Res. 2015 Feb 28;225(3):687-94. doi: 10.1016/j.psychres.2014.11.021. Epub 2014 Nov 20.
10
Treatment and Prevention of Depression.抑郁症的治疗与预防。
Psychol Sci Public Interest. 2002 Nov;3(2):39-77. doi: 10.1111/1529-1006.00008. Epub 2002 Nov 1.

引用本文的文献

1
Empowered and engaged: Group exercise for adolescent depression - perspectives from adolescents, parents and healthcare professionals.增强权能与积极参与:青少年抑郁症的团体锻炼——青少年、家长和医疗保健专业人员的观点
SAGE Open Med. 2024 Feb 3;12:20503121231225340. doi: 10.1177/20503121231225340. eCollection 2024.
2
Congruency of multimodal data-driven personalization with shared decision-making for StayFine: individualized app-based relapse prevention for anxiety and depression in young people.多模态数据驱动的个性化与共同决策在StayFine中的一致性:基于应用程序的青少年焦虑和抑郁复发预防个性化方案
Front Psychiatry. 2023 Sep 29;14:1229713. doi: 10.3389/fpsyt.2023.1229713. eCollection 2023.
3
Personalised app-based relapse prevention of depressive and anxiety disorders in remitted adolescents and young adults: a protocol of the StayFine RCT.基于个性化应用程序的缓解期青少年和年轻成年人抑郁和焦虑障碍复发预防:StayFine RCT 研究方案。
BMJ Open. 2022 Dec 15;12(12):e058560. doi: 10.1136/bmjopen-2021-058560.
4
Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.在对选择性5-羟色胺再摄取抑制剂耐药的青少年重度抑郁症患者中转换选择性5-羟色胺再摄取抑制剂:耐受性与疗效的平衡
J Child Adolesc Psychopharmacol. 2019 May;29(4):250-255. doi: 10.1089/cap.2018.0145. Epub 2019 Feb 27.
5
A next-generation social media-based relapse prevention intervention for youth depression: Qualitative data on user experience outcomes for social networking, safety, and clinical benefit.一种基于社交媒体的青少年抑郁症复发预防下一代干预措施:关于社交网络、安全性和临床益处的用户体验结果的定性数据。
Internet Interv. 2017 Jun 29;9:65-73. doi: 10.1016/j.invent.2017.06.002. eCollection 2017 Sep.
6
Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?儿童抑郁和焦虑症的抗抑郁治疗时长:多长时间才算足够?
Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):31-39. doi: 10.1016/j.cppeds.2017.12.002. Epub 2018 Jan 12.
7
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.认知行为疗法预防重度抑郁症药物治疗有反应的儿科患者复发
J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1395-404. doi: 10.1097/CHI.0b013e31818914a1.

本文引用的文献

1
The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.青少年抑郁症治疗研究(TADS):长期疗效与安全性结果
Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. doi: 10.1001/archpsyc.64.10.1132.
2
Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects.降低单相抑郁症的复发率:认知行为疗法效果的比较性荟萃分析
J Consult Clin Psychol. 2007 Jun;75(3):475-88. doi: 10.1037/0022-006X.75.3.475.
3
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).青少年抑郁症治疗研究(TADS)中急性结局的预测因素和调节因素
J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39. doi: 10.1097/01.chi.0000240838.78984.e2.
4
Acute time to response in the Treatment for Adolescents with Depression Study (TADS).青少年抑郁症治疗研究(TADS)中的急性反应时间。
J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1412-8. doi: 10.1097/01.chi.0000237710.73755.14.
5
Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).青少年抑郁症治疗研究(TADS)中短期治疗后的缓解情况及残留症状
J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11. doi: 10.1097/01.chi.0000242228.75516.21.
6
Relapse and recurrence in pediatric depression.儿童抑郁症的复发
Child Adolesc Psychiatr Clin N Am. 2006 Oct;15(4):1057-79, xi. doi: 10.1016/j.chc.2006.05.003.
7
Report by the ACNP Task Force on response and remission in major depressive disorder.美国神经精神药理学院(ACNP)关于重度抑郁症反应与缓解的特别工作组报告。
Neuropsychopharmacology. 2006 Sep;31(9):1841-53. doi: 10.1038/sj.npp.1301131. Epub 2006 Jun 21.
8
Effects of psychotherapy for depression in children and adolescents: a meta-analysis.心理治疗对儿童和青少年抑郁症的影响:一项荟萃分析。
Psychol Bull. 2006 Jan;132(1):132-49. doi: 10.1037/0033-2909.132.1.132.
9
Review of the efficacy and safety of antidepressants in youth depression.抗抑郁药治疗青少年抑郁症的疗效与安全性综述。
J Child Psychol Psychiatry. 2005 Jul;46(7):735-54. doi: 10.1111/j.1469-7610.2005.01467.x.
10
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.氟西汀预防儿童和青少年抑郁症复发的治疗:一项双盲、安慰剂对照研究。
J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1397-405. doi: 10.1097/01.chi.0000140453.89323.57.